Thematische Bibliographien / Nausea and vomiting in pregnancy

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen
Bücher
Buchteile
Konferenzberichte
Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Nausea and vomiting in pregnancy“

Autor: Grafiati

Veröffentlicht am 23. Mai 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Nausea and vomiting in pregnancy" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Nausea and vomiting in pregnancy"

Firoz, Tabassum, Caroline Maltepe und Adrienne Einarson. „Nausea and Vomiting in Pregnancy Is Not Always Nausea and Vomiting of Pregnancy“. Journal of Obstetrics and Gynaecology Canada 32, Nr. 10 (Oktober 2010): 970–72. http://dx.doi.org/10.1016/s1701-2163(16)34685-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cisek, Anna, und Marzena Bucholc. „Assessment of the severity of nausea and vomiting among women during pregnancy vs. selected risk factors“. Polish Journal of Public Health 125, Nr. 4 (01.12.2015): 197–200. http://dx.doi.org/10.1515/pjph-2015-0054.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction. It is estimated that 90% of pregnant women suffer from nausea and vomiting (NVP). The severity of NVP may vary and the first symptoms tend to appear between the 4th and 9th week of pregnancy, reaching their peak around 7th-12th week and disappear around 16th-20th week of pregnancy. The etiology of both nausea and vomiting is yet to be discovered, yet there is a number of factors that may contribute to it. These symptoms usually accompany the increase of human chorionic gonadotropin (hCG) and most intensive ailments associated to the highest rate of this hormone appear around the 10th week of pregnancy. Aim. Assessing the severity of nausea and vomiting in pregnant women and selected risk factors. Material and methods. The study group consisted of 150 women hospitalized in the Independent Public Teaching Hospital No 4 in Lublin. The head of the Department of Obstetrics and Perinatology Agreement has agreed for the studies to be conducted. The authors used a research tool named modified scale Pregnancy Unique Quantification of Emesis which allowed to investigate the incidence and severity of nausea and vomiting during pregnancy. Demographic data and information on the conditions of nausea and vomiting in pregnancy were collected using a questionnaire survey of the authors’ own making. Database and statistical tests were conducted using 10.0 STATISTICA software (StatSoft, Poland). Results. The analysis revealed that 108 women (72.00%) experienced nausea or vomitting during pregnancy. Taking into consideration the first trimester of pregnancy, a moderate severity of nausea and vomiting (NVP) occurred with an average of 6.51±3.17 pt. It was found that 82 respondents had light intensity of NVP, whereas 68 moderate. In the second trimester an average intensity of nausea and vomiting (NVP) came to 4.82±2.45 pt, i.e. 117 women had mild symptoms while 33 had moderate symptoms. During the third trimester NVP severity dropped to 3.88±1.67. The majority of respondents stated that nausea and vomiting was of light intensity (92.00%), while 8% declared that it was moderate. Conclusions. The severity of nausea and/or vomiting varies in the course of pregnancy, with significantly more moderate than mild symptoms occurring in the first compared to other trimesters of gestation. The degree of the severity of NVP in the third trimester of pregnancy is significantly affected by risk factors occurring before pregnancy (migraine headache, nausea or vomiting), and co-morbidities. However, the number of pregnancies, the fact whether the pregnancy was planned or not, motion sickness do not have major significance in this matter.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kouzi, Samir A. „Nausea and Vomiting of Pregnancy“. American Journal of Pharmaceutical Education 67, Nr. 2 (September 2003): 66. http://dx.doi.org/10.5688/aj670266.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Niebyl, Jennifer R. „Nausea and Vomiting in Pregnancy“. New England Journal of Medicine 363, Nr. 16 (14.10.2010): 1544–50. http://dx.doi.org/10.1056/nejmcp1003896.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Davis, Mitzi. „Nausea and Vomiting of Pregnancy“. Journal of Perinatal & Neonatal Nursing 18, Nr. 4 (Oktober 2004): 312–28. http://dx.doi.org/10.1097/00005237-200410000-00002.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kramer, Jennifer, Angela Bowen, Norma Stewart und Nazeem Muhajarine. „Nausea and Vomiting of Pregnancy“. MCN, The American Journal of Maternal/Child Nursing 38, Nr. 1 (2013): 21–27. http://dx.doi.org/10.1097/nmc.0b013e3182748489.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lane, Carolyn A. „Nausea and Vomiting of Pregnancy“. Postgraduate Obstetrics & Gynecology 28, Nr. 4 (Februar 2008): 1–7. http://dx.doi.org/10.1097/01.pgo.0000311519.20099.e1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

&NA;. „Nausea and Vomiting of Pregnancy“. Postgraduate Obstetrics & Gynecology 28, Nr. 4 (Februar 2008): 8. http://dx.doi.org/10.1097/01.pgo.0000311520.14261.0b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Koch, Kenneth L., und Christine L. Frissora. „Nausea and vomiting during pregnancy“. Gastroenterology Clinics of North America 32, Nr. 1 (März 2003): 201–34. http://dx.doi.org/10.1016/s0889-8553(02)00070-5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Broussard, Crystal N., und Joel E. Richter. „NAUSEA AND VOMITING OF PREGNANCY“. Gastroenterology Clinics of North America 27, Nr. 1 (März 1998): 123–51. http://dx.doi.org/10.1016/s0889-8553(05)70350-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Nausea and vomiting in pregnancy"

Al-Rasasi, Buthaina. „Nausea and vomiting in pregnancy, maternal nutrition and pregnancy outcome“. Thesis, University of Surrey, 2003. http://epubs.surrey.ac.uk/843490/.

Der volle Inhalt der Quelle

Annotation:

Nausea and vomiting in pregnancy (NVP), which is known to affect nearly 70% of all pregnant women, has been associated with favourable pregnancy outcomes such as decreased risk of miscarriage, low birth weight and premature delivery. The aim of this research was to determine the mechanism by which these protective effects of NVP may be brought about. Women suffering from NVP may decrease their intake due to the symptoms, may increase their intake to alleviate symptoms, or may change the quality of their diet. Both a retrospective questionnaire survey (n=201) and a prospective cohort study (n=52) were carried out between April 1999 and August 2001. Women were recruited mainly from two GP clinics in Guildford. It was found from both studies that the prevalence of NVP in the Guildford area is similar to that reported in other studies. Although this study found no relationship between NVP and birth weight and gestational age, women with NVP had higher cord IGF-1 levels compared to women without NVP (p=0.044). In addition, duration of NVP was inversely related to birthweight to placental ratio (p=0.011). Forty three women provided complete dietary information. It was found that energy intakes did not differ between women who had NVP compared with women who had no NVP, however the quality of diet varied between women with NVP and those without NVP. This is probably due to the fact that women with NVP had a high risk of cravings and aversions in pregnancy, leading to the difference in intake of certain nutrients such as riboflavin, calcium, zinc and copper. The strong association between NVP and aversions in pregnancy (P= 0.026) found in the retrospective study could lend further support to the "Embryo protection" hypothesis, which states that NVP is a protective mechanism, which has evolved to prevent the mother from the ingestion of foods that could be harmful to the fetus. Further studies using larger sample sizes, covering a range of socio-economic status and different regions are needed before definite conclusions can be drawn.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Swallow, Brian L. „Nausea and vomiting in pregnancy : psychological and social aspects“. Thesis, University of Lincoln, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.496084.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Smith, Caroline Anne. „Acupuncture to treat nausea and vomiting in early pregnancy : a randomised controlled trial“. Title page, contents and abstract only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09phs644.pdf.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mazzotta, Paolo. „Nausea and vomiting of pregnancy, misperception of drug use and major adverse events“. Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0005/MQ34080.pdf.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chou, Fan-hao. „The adaptation to pregnancy in Taiwanese women who experience different severities of nausea and vomiting“. Access restricted to users with UT Austin EID Full text (PDF) from UMI/Dissertation Abstracts International, 2001. http://wwwlib.umi.com/cr/utexas/fullcit?p3036170.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chandra, Kiran. „Development of a health-related quality of life (HRQL) instrument for nausea and vomiting in pregnancy (NVP)“. Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape4/PQDD_0015/MQ54162.pdf.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Viljoen, Estelle. „A systematic review of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting“. Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/20265.

Der volle Inhalt der Quelle

Annotation:

Thesis (MNutr)--Stellenbosch University, 2012.
ENGLISH ABSTRACT: Background: Nausea and vomiting during pregnancy (NVP) is a common medical condition. Due to possible harmful side-effects that conventional medicine may pose to the fetus, many mothers choose not to use it, and are left helpless against NVP. There is a need for alternative treatment to relieve NVP symptoms. Objectives: This systematic review (SR) investigated current evidence regarding ginger for the treatment of NVP. The primary objective was to assess the effectiveness of ginger in treating NVP. The secondary objective was to assess the safety of ginger during pregnancy, by identifying adverse events or side-effects. Search strategy: Electronic search of bibliographic databases (1966-February 2011). Selection criteria: Randomized controlled trials (RCTs) of the efficacy of ginger by any route, as treatment for NVP in pregnant women regardless of their age or stage of pregnancy. Data collection and analysis: The principal investigator and independent reviewer individually identified relevant studies, extracted data and assessed trial quality. Data analysis was performed using the RevMan5 software. Differences at the level of p<0.05 were considered to be statistically significant. Results: Eleven RCTs involving 1176 pregnant women were included. The quality of evidence was low, hence the high risk of bias and imprecision of results. Ginger significantly improved the symptoms of nausea when compared to placebo, when comparing the results of this SR to past SRs, and taking into account a meta-analysis performed on two relatively large included studies (mean difference (MD) 1.20, 95% confidence interval (CI) 0.56-1.84, p=0.0002, I2=0%). However, another meta-analysis on two smaller studies indicated no significant improvement in nausea. Ginger did not significantly improve nausea when compared to vitamin B6 (MD 0.34, 95% CI -1.52-2.20, p=0.7, I2=91%). Similarly, ginger did not significantly reduce the number of vomiting episodes during NVP, when compared to placebo, although there was a trend towards improvement (MD 0.72, 95% CI -0.03-1.46, p=0.06, I2=71%). Subgroup analyses performed seemed to favor the lower daily dosage of <1500mg ginger to possibly be more effective for the relief of nausea. Ginger did not pose a significant risk for spontaneous abortion when compared to placebo (RR 3.14, 95% CI 0.65-15.11, p=0.15; I2=0%), or to vitamin B6 (RR 0.49, 95% CI 0.17-1.42, p=0.19, I2=40%). Similarly, ginger did not pose a significant risk for the side effects of heartburn or drowsiness when compared to placebo or vitamin B6. When compared to dimenhydrinate, ginger posed a smaller risk for drowsiness (RR 0.08, 95% CI 0.03-0.18) and no increased risk for heartburn. Conclusions: This review suggests potential benefits of ginger in reducing nausea symptoms in pregnancy (bearing in mind the limited number of studies, variable outcome reporting and quality of evidence). Ginger did not have a significant impact on vomiting episodes, nor pose a risk for side effects or adverse events during pregnancy. Based on evidence from this SR, ginger could be considered a harmless and possibly effective alternative option for women suffering from the symptoms of NVP. Large RCTs are necessary to confirm the possible benefit of ginger as treatment for NVP.
AFRIKAANSE OPSOMMING: Agtergrond: Naarheid en vomering tydens swangerskap (NVS) is ‘n algemene mediese toestand. As gevolg van moontlike skadelike newe-effekte wat konvensionele medikasie kan veroorsaak vir die fetus, vermy baie moeders dit en word hulpeloos gelaat teen NVS. Dus is daar behoefte aan alternatiewe behandeling vir NVS. Doelwitte: Hierdie sistematiese literatuuroorsig (SO) het huidige literatuur ondersoek wat verband hou met gemmer vir behandeling van NVS. Die primêre doelwit was om effektiwiteit van gemmer as behandeling vir NVS te assesseer. Die sekondêre doelwit was om veiligheid van gemmer tydens swangerskap te assesseer, deur ongunstige gebeure en newe-effekte te identifiseer. Soektogstrategie: Elektroniese soektog van bibliografiese databasisse (1966-Februarie 2011). Seleksiekriteria: Verewekansigde gekontrolleerde proewe (RCTs) van gemmer deur enige roete as behandeling van NVS, in swanger vroue ongeag ouderdom of stadium van swangerskap. Dataversameling en –analise: Die hoof navorser en ‘n onafhanklike hersiener het individueel relevante studies geidentifiseer, data ekstraksie onderneem en studie-kwaliteit geassesseer. Data-analise is uitgevoer deur die RevMan5 sagteware te gebruik. Verskille by die vlak van p<0.05 was beskou as statisties betekenisvol. Hoof resultate: Elf RCTs waarby 1176 swanger vroue betrokke was, is ingesluit. Die studie-kwaliteit was swak, dus die hoë risiko vir sydigheid en onakkuraatheid van resultate. Gemmer het beduidend die simptome van naarheid verbeter in vergelyking met plasebo, wanneer die resultate van hierdie SO met vorige SO’s vergelyk word, en die meta-analise in ag geneem word wat op twee relatiewe groot ingeslote studies uitgevoer is (gemiddelde verskil (MD) 1.20, 95% vertrouens interval (VI) 0.56-1.84, p=0.0002,I2=0%). Kontrasterend, het ‘n ander meta-analise van twee kleiner studies geen beduidende verbetering in naarheid aangedui nie. Gemmer het nie beduidend naarheid verbeter wanneer dit met vitamien B6 vergelyk word nie (MD 0.34, 95% VI -1.52-2.20, p=0.7, I2=91%). Soortgelyk, het gemmer nie die aantal vomerings-episodes verminder, in verglyking met plasebo nie, maar daar was wel ‘n neiging na verbetering (MD 0.72, 95% VI -0.03-1.46, p=0.06, I2=71%). Die subgroup-analise blyk ten gunste te wees van die laer daaglikse dosis van <1500mg gemmer om meer effektief te wees vir die behandeling van naarheid. Gemmer het nie ‘n beduidende risiko ingehou vir spontane aborsie, wanneer dit vergelyk word met plasebo (relatiewe risiko (RR) 3.14, 95% VI 0.65-15.11,p=0.15;I2=0%), of vitamien B6 nie (RR 0.49, 95% VI 0.17-1.42,p=0.19;I2=40%). Soortgelyk, het gemmer nie ‘n beduidende risiko ingehou vir newe-effekte van sooibrand of duiseligheid, wanneer dit vergelyk word met plasebo of vitamien B6 nie. Wanneer dit vergelyk word met dimenhidrinaat, het gemmer ‘n kleiner risiko ingehou vir duiseligheid (RR 0.08, 95% VI 0.03-0.18) en geen verhoogde risiko vir sooibrand nie. Gevolgtrekkings: Hierdie SO dui ‘n potensiële voordeel van gemmer aan in vermindering van naarheid tydens swangerskap (inagnemend van die klein hoeveelheid studies, wisselende uitkomste-rapportering en studie-kwaliteit). Gemmer het nie ‘n beduidnede impak gehad op vomerings-episodes nie, en ook nie ‘n risiko ingehou vir newe-efekte of ongunstige gebeure tydens swangerskap nie. Volgens bewyse uit hierdie SO, kan gemmer beskou word as ‘n skadelose en moontlike effektiewe alternatiewe opsie vir vroue wat lei aan NVP. Grootskaalse RCTs is nodig om die moontlike voordeel van gemmer as behandeling vir NVS te bevestig.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chan, Ronna L. Olshan Andrew F. Savitz David A. „Maternal health exposures and pregnancy outcome examining symptoms of nausea and vomiting in early pregnancy, maternal caffeine consumption, and spontaneous abortion utilizing regression and propensity score methodologies /“. Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2008. http://dc.lib.unc.edu/u?/etd,2157.

Der volle Inhalt der Quelle

Annotation:

Thesis (Ph. D.)--University of North Carolina at Chapel Hill, 2008.
Title from electronic title page (viewed Feb. 26, 2009). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Maternal and Child Health reproductive epidemiology, School of Public Health." Discipline: Maternal and Child Health; Department/School: Public Health.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Sartori, Julie A. „Morning sickness and the placenta“. Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2023. https://ro.ecu.edu.au/theses/2728.

Der volle Inhalt der Quelle

Annotation:

Background: Nausea and vomiting in pregnancy (NVP) is considered one of the ultimate reproductive health dilemmas and often misunderstood both biologically and conceptually. This phenomenon occurs in approximately eighty percent of pregnancies worldwide and there are many theories relating to the cause of symptoms, however, no origin has been identified. Morning sickness will be discussed primarily within a physiological framework that focuses on maternal characteristics, placental structure, and related birth outcomes. Interestingly, vomiting in pregnancy appears to be unique to the human species, which from an evolutionary medical perspective is thought to be the result of human adaptation to varying internal and external environments. Some human adaptations or the consequential effects of these adaptations are not always viewed as favourable, from our twenty-first century medical point of view. Women with an absence of NVP symptoms in pregnancy are understudied and therefore, an essential and informative addition to this cohort. Aims: The primary focus of this research project was to investigate NVP in relation to maternal characteristics, placental structure, and birth outcomes in singleton pregnancies. This study also included an important subset of expectant mothers with no reported NVP symptoms. Characteristics of morning sickness for expectant mothers with pregnancies resulting from ART and non-ART conception were examined. Psychosocial outcome variables and morning sickness status were compared using three specific measures from the maternal health questionnaire (MHQ) [Social Provision Scale (SPS), Pregnancy Distress Scale (PDQ) and the Perceived Stress Scale (PSS)], and the Edinburgh Postnatal Depression Scale (EPDS) from the maternal medical records. Data generated from the MHQ, gross placental morphology, maternal and natal medical records were examined to determine the associations between morning sickness, placental structure, and birth outcomes (e.g., low birth weight, placental weight, and birth weight to placental weight ratio). A unique addition to this study was the consideration of the placental microbiome as a potential contributing factor to differences in women with different NVP status. Methods: To investigate NVP characteristics and examine the role of the human placenta and NVP status, 625 expectant mothers with singleton pregnancies were recruited from two major hospitals in Perth, Western Australia. Pregnancies were the result of natural and assisted conception and expectant mothers participated in a cross- sectional survey consisting of a MHQ, and gross placental examination using gross morphologic analysis. On completion of placental analyses, data from the maternal and natal medical records were collected and characteristics compared for women with differing nausea and vomiting status. The characteristics of NVP were identified through statistical analyses of the data, including significant medical, clinical, and psychosocial factors. Gross placental morphology measures and birth outcomes were compared according to NVP status. Results: NVP was experienced by most expectant mothers in this cohort (79%) with 21% of women experiencing no NVP and 3% clinically diagnosed with hyperemesis gravidarum (HG). Nausea was the most prevalent symptom followed by food avoidance and women were more likely to report the frequency of these symptoms as continuous, while retching and vomiting were episodic in nature. Symptoms were self-rated as moderate to severe, and all risk factors were positively correlated with NVP. Women with HG recorded associated variables including increased symptom frequency and severity, medication use and a majority of the risk factors from the MHQ. The severity and frequency of symptoms were significantly associated with a number of maternal characteristics including age of menarche, increased maternal weight/obesity on first antenatal booking and admission for delivery of the baby. Increased psychosocial measures noted for women with NVP were related to the frequency and severity of symptoms. This was consistent for women who experienced HG and had pregnancies resulting from ART. ART treatments were also associated with an increased frequency and severity of symptoms. Women experiencing NVP reported higher overall scores for the Pregnancy Distress Questionnaire and Perceived Stress Scale when compared to women who had no NVP, and evaluation of the Social Provision Scale identified women with NVP had lower self-rating scores for Nurturance and Attachment. Women in this study delivered normal healthy babies, with normal BW/PWR and ponderal index ranges. Placental measures were similar for NVP status groups across this cohort and a majority fell within the 10th and 90th centiles for BW and placental weight. Evaluation of placental weight for women with clinically diagnosed HG in ART and non-ART pregnancies found that women who conceived naturally and experienced HG had an increased trimmed placental weight (grams). Women with HG who conceived using ART were more likely to have a lower placental weight. This was the first study to explore the association between the placental amniochorionic microbiome and morning sickness status in women with singleton pregnancies. Significant differences in microbial diversity were noted between NVP status groups. Women with NVP had a higher species diversity and those in the No NVP group having a lower microbial diversity. Clinical relevance: This comprehensive study has produced new and insightful information, highlighting the role of maternal characteristics and placental development in maternal health and birth outcomes. A detailed examination of NVP and the relationship between NVP symptoms, have highlighted the need for research that explores symptom frequency and severity rather than the presence or absence of symptoms alone. Examination of medical and clinical characteristics for women with and without NVP have provided new theoretical understanding and this current research provides evidence-based findings linking NVP and placental anatomy that are important for perinatal health. Future research examining the biological mechanisms and NVP symptom expression would be valuable. As part of reproductive health, ongoing research that promotes clinical understanding and the effective management of nausea and vomiting in pregnancy will decrease patient distress and foster practitioner confidence. Documentation of key concepts related to the physiology of nausea and vomiting in pregnancy can provide an understanding of the pathways that lead to NVP. Expectant mothers will be empowered by having access to updated information promoting maternal and natal health outcomes. Importantly, information should be provided to partners, family, friends, and caregivers to assist, nurture and support all expectant mothers.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Hines, Sonia Jane. „Aromatherapy for postoperative nausea and vomiting“. Thesis, Queensland University of Technology, 2012. https://eprints.qut.edu.au/60245/1/Sonia_Hines_Thesis.pdf.

Der volle Inhalt der Quelle

Annotation:

Background: Postoperative nausea and vomiting is one of the most common adverse reactions to surgery and all types of anaesthesia and despite the wide variety of available antiemetic and anti-nausea treatments, 20-30% of all patients still suffer moderate to severe nausea and vomiting following general anaesthesia. While aromatherapy is well-known and is used personally by nurses, it is less well utilised in the healthcare setting. If aromatherapy is to become an accepted adjunct treatment for postoperative nausea and vomiting, it is imperative that there is both an evidence base to support the use of aromatherapy, and a nursing workforce prepared to utilise it. Methods: This involved a Cochrane Systematic Review, a Delphi process to modify an existing tool to assess beliefs about aromatherapy to make it more relevant to nursing and midwifery practice, and a survey to test the modified tool in a population of nurses and midwives. Findings: The systematic review found that aromatherapy with isopropyl alcohol was more effective than placebo for reducing the number of doses of rescue antiemetics required but not more effective than standard antiemetic drugs. The Delphi panel process showed that the original Beliefs About Aromatherapy Scale was not completely relevant to nursing and midwifery practice. The modified Nurses' Beliefs About Aromatherapy Scale was found to be valid and reliable to measure nurses' and midwives' beliefs about aromatherapy. Factor analysis supported the construct validity of the scale by finding two sub-scales measuring beliefs about the 'usefulness of aromatherapy' and the 'scientific basis of aromatherapy'. Survey respondents were found to have generally positive beliefs about aromatherapy, with more strongly positive beliefs on the 'usefulness of aromatherapy' sub-scale. Conclusions: From the evidence of the systematic review, the use of isopropyl alcohol vapour inhalation as an adjunct therapy for postoperative nausea and vomiting is unlikely to be harmful and may reduce nausea for some adult patients. It may provide a useful therapeutic option, particularly when the alternative is no treatment at all. Given the moderately positive beliefs expressed by nurses and midwives particularly about the usefulness of aromatherapy there is potential for this therapy to be implemented and used to improve patient care.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Bücher zum Thema "Nausea and vomiting in pregnancy"

Julian, Woolfson, Hrsg. Nausea and vomiting in pregnancy: An integrated approach to care. Edinburgh: Churchill Livingstone, 2004.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chandra, Kiran. Development of a health-related quality of life (HRQL) instrument for nausea and vomiting in pregnancy (NVP). Ottawa: National Library of Canada, 2000.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Koch, Kenneth L., und William L. Hasler, Hrsg. Nausea and Vomiting. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-34076-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kehlet, Henrik. Postoperative Nausea and Vomiting. Herausgegeben von Tong Joo Gan und Ashraf S. Habib. Cambridge: Cambridge University Press, 2016. http://dx.doi.org/10.1017/cbo9781316135853.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

C, Kenny G. N., Rowbotham David John, Glaxo Laboratories Ltd und Synergy Medical Education, Hrsg. Postoperative nausea and vomiting. London: Synergy Medical Education, 1992.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

J, Gan Tong, Hrsg. Post-operative nausea and vomiting. Philadelphia, Penn: Lippincott Williams & Wilkins, 2003.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Davis, Christopher J., Gerry V. Lake-Bakaar und David G. Grahame-Smith, Hrsg. Nausea and Vomiting: Mechanisms and Treatment. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70479-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

H, Sleisenger Marvin, Hrsg. The Handbook of nausea and vomiting. New York: Published in association with Caduceus Medical Publishers by the Parthenon Publishing Group, 1993.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

H, Sleisenger Marvin, Hrsg. The Handbook of nausea and vomiting. New York: Published in association with Caduceus Medical Publishers by the Parthenon Publishing Group, 1993.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

1950-, Davis C. J., Lake-Bakaar G. V. 1948-, Grahame-Smith David Grahame, Janssen Pharmaceutical Ltd. Medical Dept. und Janssen Pharmaceutica, Hrsg. Nausea and vomiting: Mechanisms and treatment. Berlin: Springer-Verlag, 1986.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Buchteile zum Thema "Nausea and vomiting in pregnancy"

Dilorio, Colleen K., und Donna J. van Lier. „Nausea and Vomiting in Pregnancy“. In Management of Pain, Fatigue and Nausea, 259–66. London: Macmillan Education UK, 1989. http://dx.doi.org/10.1007/978-1-349-13397-0_32.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Minocha, Anil. „Nausea and Vomiting of Pregnancy“. In A Guide to Alternative Medicine and the Digestive System, 168–71. Boca Raton: CRC Press, 2024. http://dx.doi.org/10.1201/9781003524427-47.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Swaby, Laurie-Anne C., und Kim L. Isaacs. „Nausea and Vomiting of Pregnancy“. In GI and Liver Disease During Pregnancy, 13–29. Boca Raton: CRC Press, 2024. http://dx.doi.org/10.1201/9781003524359-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Arnold, Kate C., und Caroline J. Flint. „Nausea and Vomiting of Pregnancy“. In Obstetrics Essentials, 209–15. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57675-6_32.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Walker, Ted, und Gregory S. Sayuk. „Nausea and Vomiting of Pregnancy and Postoperative Nausea and Vomiting“. In Essential Medical Disorders of the Stomach and Small Intestine, 51–74. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-01117-8_3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gupta, Anjeleena Kumar. „Postoperative Nausea and Vomiting“. In Peripartum Care of the Pregnant Patient, 291–98. Cham: Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-62756-9_36.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Boelig, Rupsa C., und Sofia Guidi. „Nausea/Vomiting of Pregnancy and Hyperemesis Gravidarum“. In Maternal-Fetal Evidence Based Guidelines, 99–110. 4. Aufl. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003099062-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Boelig, Rupsa C. „9. Nausea/vomiting of pregnancy and hyperemesis gravidarum“. In Maternal-Fetal Evidence Based Guidelines, 3e, 92–102. Taylor & Francis Group, 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742: CRC Press, 2016. http://dx.doi.org/10.1201/9781315200910-10.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Saha, Sumona. „Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum“. In Gastrointestinal and Liver Disorders in Women’s Health, 249–63. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25626-5_16.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Goodwin, T. Murphy, und Martin N. Montoro. „Nausea and Vomiting of Pregnancy Including Hyperemesis Gravidarum“. In Management of Common Problems in Obstetrics and Gynecology, 165–71. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444323030.ch36.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Nausea and vomiting in pregnancy"

Handayani, Nanik. „Effectiveness of Acupressure on Reducing of Nausea and Vomiting in Pregnant Women in Independent Midwifery Practice, Sidoarjo, East Java“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.52.

Der volle Inhalt der Quelle

Annotation:

ABSTRACT Background: During pregnancy, there can be various pregnancy complications, including nausea and vomiting, which is often experienced by pregnant women. This condition is one of the earliest symptoms of pregnancy. This nausea and vomiting are physiological. This physiological condition will turn into a pathology if not appropriately treated. This study aimed to analyze the effect of acupressure on reducing nausea and vomiting in pregnant women at the Sidoarjo midwife’s independent practice. Subjects and Method: This study is a quasi-experiment with pre and post-test control group design conducted at Midwife Independent Practice, Sidoarjo from April to September, 2020. The dependent variable was nausea and vomiting. The independent variable was acupressure. The population of all primigravida pregnant women who experience nausea and vomiting. A sample of 40 was divided into 20 given intervention and 20 as control selected by purposive sampling. The data were collected by acupressure SOP and questionnaire with a Score Pregnancy Unique Quantification of Emesis and or Nausea Scoring System (PUQE) assessment. The data were analyzed by Wilcoxon and Mann Whitney. Results: The results showed that acupressure was effective in reducing nausea and vomiting in primigravida pregnant women (OR = 19.00; 95% CI = 2.11 to 5.13; p= 0.009). Conclusion: Acupressure is effective in reducing nausea and vomiting in primigravida pregnant women. Keywords: acupressure, pregnant women, nausea and vomiting Correspondence: Nanik Handayani. Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, East Java. Jl. Smea No 57 Surabaya. Email: nanik_handayani@unusa.ac.id. Mobile: 08123278582. DOI: https://doi.org/10.26911/the7thicph.03.52

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Fitria, Nurhidaya, und Ida Lestari Tampubolon. „The Effect of Ginger Extract Consumption on Reducing Morning Sickness in First Trimester of Pregnant Women at Pratama Mariana Clinic Medan, North Sumatra“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.44.

Der volle Inhalt der Quelle

Annotation:

ABSTRACT Background: Nausea and vomiting are common in pregnant women, and the condition may be a mild or severe disabling disease. Nausea and vomiting are common in the early stages of pregnancy, affecting 70-80% of pregnant mothers. In most women, vomiting begins between 4-7 weeks of pregnancy. Nausea and vomiting are usually mild and self-limiting, but some mothers have a deeper course and cause pregnancy vomiting. This study aimed to analyze the effectiveness of ginger extract consumption on reducing morning sickness in first trimester of pregnant women at Pratama Mariana Clinic Medan, North Sumatra. Subject and Method: This was a quasi experiment study with pretest-posttest control group design conducted in Pratama Mariana Clinic, Medan from July to August 2018. A sample of 15 pregnant women. The dependent variable was emesis gravidarum. The independent variable was extract of ginger. The data were collected by observation and analyzed by wilcoxon test. Result: The extract of ginger is effective to reduce nausea and vomiting in first trimester pregnancy women after ginger extract was given (Mean= 1.93; SD= 0.26) was higher than before (Mean= 1.20; SD= 0.41), and it was statistically significant (p <0.001). Conclusion: The extract of ginger is effective to reduce nausea and vomiting in first trimester pregnancy women after ginger extract Keywords: Emesis gravidarum, extract of ginger Correspondence: Nurhidaya Fitria. Helvetia Institute of Health, Sumatera Utara. Email: nurhidayafitria@gmail.com. Mobile: 082385317328. DOI: https://doi.org/10.26911/the7thicph.03.44

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dewi, Rahma Kusuma, und Halimatus Saidah. „Relationship between Gravidity and Severity of Emesis Gravidarum in Trimester I Pregnant Women at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.77.

Der volle Inhalt der Quelle

Annotation:

ABSTRACT Background: Emesis gravidarum or nausea and vomiting has commonly occurred during pregnancy. However, excessive nausea and vomiting in early pregnancy have a potentially adverse effect on pregnancy outcomes. This study aimed to investigate the relationship between gravidity and severity of emesis gravidarum in women with first-trimester of pregnancy at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java. Subjects and Method: This was a cross-sectional study conducted at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java, from July to August 2020. A sample of 32 women with first-trimester of pregnancy was selected for this study. The dependent variable was severity of emesis gravidarum categorized into mild to moderate and severe. The independent variable was the number of gravidities categorized into primigravida and multigravida. The data were collected using questionnaire. The data were analyzed by chi-square. Results: Multigravida reduced the severity of emesis gravidarum (OR= 0.14; 95% CI= 0.02 to 0.85; p= 0.034). Conclusion: Multigravida reduces the severity of emesis gravidarum in women with first-trimester pregnancy. Keywords: emesis gravidarum, first trimester, gravidity, severity, pregnant women Correspondence: Rahma Kusuma Dewi. Faculty of Health Sciences, Universitas Kadiri. Jl. Selomangleng No 1, Kediri, East Java. Email: rahmakusumadewi@unik-kediri.ac.id. Mobile: +6281229440101. DOI: https://doi.org/10.26911/the7thicph.03.77

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Tambelli, Renata. „Depressive Symptoms Postpartum: A Study On Women With Nausea/Vomiting During Pregnancy“. In 5th International Conference on Health and Health Psychology: Covid-19 and Health Care. European Publisher, 2020. http://dx.doi.org/10.15405/eph.20101.10.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Agus, Yenita, und Rutfika Hidayat. „The Effect of Ginger Water and Mint Leaves for Reduce Nausea and Vomiting in the 1st Trimester of Pregnancy“. In Proceedings of the 1st International Conference on Health Science, ICHS 2020, 26-27 October 2020, Jakarta, Indonesia. EAI, 2021. http://dx.doi.org/10.4108/eai.26-10-2020.2311321.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mangler, M., K. Kuhlmann, F. Kohlhepp, T. Steeb und W. E. Paulus. „‘Investigating patients’ attitudes towards the treatment of nausea and vomiting of pregnancy: results of a German nationwide online study“. In 65. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1790854.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Henukh, Dina Melanieka Sintikhe, Siti Nur Asyah und Jamillah Ahmad. „The Association between Maternal Age and Gravidity and the Event of Gravidarum Emesis in Kupang, East Nusa Tenggara“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.01.

Der volle Inhalt der Quelle

Annotation:

Background: Emesis gravidarum or better known as morning sickness is a symptom of nausea which is usually accompanied by vomiting which generally occurs in early pregnancy, usually in the first trimester. This condition is generally experienced by more than half of pregnant women due to hormonal changes. This study aimed to analyze the association between maternal age and gravidity and the event of gravidarum emesis in Kupang, East Nusa Tenggara. Subjects and Method: This was a cross-sectional study conducted at the Tenau Auxiliary Community Health Center, Kupang City, East Nusa Tenggara, from February to June 2019. Total of 60 pregnant women were enrolled in this study. The independent variables were maternal age and gravidity. The dependent variable was emesis gravidarum. The data were collected using a questionnaire and analyzed using the Chi-Square. Results: Total of 68.3% of pregnant women were experienced emesis. 92.7% aged 20-35 years and 7.3% aged <20 years. 84.2% of pregnant women did not experience emesis aged 20-35 years and aged> 35 years were 15.8%. Most of the pregnant women who experienced emesis were primigravida (51.2%) and multigravidas (48.8%). 84.2% of mothers did not experience multigravida emesis and did not experience primigravidas emesis (15.8%), and they were statistically significant. Conclusion: Maternal age and gravidity are positively relate to the incidence of emesis gravidarum among pregnant women. Keywords: age, gravidity, emesis gravidarum Correspondence: Dina Melanieka Sintikhe Henukh. Study Program of Midwifery, Universitas Citra Bangsa, Kupang, East Nusa Tenggara. Jl. Bhakti Warga 34, East Nusa Tenggara. Email: Dinnahenukh@gmail.com. Mobile +6285238629495 DOI: https://doi.org/10.26911/the7thicph.03.01

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Handayani, Nanik. „EFFECTIVENESS OF ACUPRESSURE ON REDUCING OF NAUSEA AND VOMITING IN PREGNANT WOMEN IN INDEPENDENT MIDWIFERY PRACTICE, SIDOARJO, EAST JAVA“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph-fp.03.07.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Sakai, Chizuru, Hirotoshi Iihara, Mototsugu Shimokawa, Yukiyoshi Fujita, Shinnosuke Ikemura, Chiemi Hirose, Mie Kotake et al. „Low dose olanzapine for carboplatin-induced nausea and vomiting“. In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2299.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

„Clinical Analysis of Nausea and Vomiting in Patients with Gastrointestinal Diseases“. In 2018 3rd International Conference on Life Sciences, Medicine, and Health. Francis Academic Press, 2018. http://dx.doi.org/10.25236/iclsmh.18.005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Nausea and vomiting in pregnancy"

Chen, Xi, Han Zhang, Youchun Hu, Adwoa N. Amoah, Rong Fu, Yanfang Qiu, Yuan Cao, Yanhua Liu und Quanjun Lyu. The Efficacy of acupressure for nausea and vomiting during pregnancy: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0147.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

de Carvalho, Clístenes Crístian, Ioannis Kapsokalyvas und Kariem El-Boghdadly. Second-generation supraglottic airways vs endotracheal tubes in adults undergoing abdominopelvic surgeries: a protocol for a systematic review with pairwise meta-analyses of randomised clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0041.

Der volle Inhalt der Quelle

Annotation:

Review question / Objective: We aim to compare second-generation supraglottic airways with endotracheal tubes for perioperative safety and quality of postoperative recovery as well as for ventilation performance and risk of pulmonary aspiration. Eligibility criteria: Inclusion criteria will be as follows: randomized clinical trials; human patients aged ≥ 16 years undergoing abdominopelvic procedures under general anaesthesia from any population (e.g., general population, pregnant women, obese patients); data available on any outcome related to insertion performance (e.g., failed first attempt, failed insertion, and time to insertion), ventilation efficacy (e.g., leak pressure, leak fraction, and ventilation inadequacy), risk of regurgitation and aspiration (e.g., gastric insufflation, regurgitation, and aspiration), quality of postoperative recovery (e.g., sore throat, hoarseness, and postoperative nausea and vomiting [PONV]), and major complications (e.g., laryngospasm, bronchospasm, and hypoxemia); and comparison between any second-generation SGA and an endotracheal tube. We will exclude: studies reported in a language that prevent us of extracting relevant information; outcomes with no objective data presented (i.e., effect sizes, measures of dispersion, frequency, etc.); and studies with contradictory data.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ariyanayagam, Rachel, und Bobby krishnachetty. PAEDIATRIC POST-OPERATIVE NAUSEA AND VOMITING. World Federation of Societies of Anaesthesiologists, August 2022. http://dx.doi.org/10.28923/atotw.479.

Der volle Inhalt der Quelle

Annotation:

This tutorial covers the physiology of vomiting, risk factors for post-operative nausea and vomiting (PONV) in children, methods of risk reduction, and both pharmacological and non-pharmacological strategies for preventing and managing paediatric PONV.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Johnson, Corey, Colton James, Sarah Traughber und Charles Walker. Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex. University of Tennessee Health Science Center, Juli 2021. http://dx.doi.org/10.21007/con.dnp.2021.0005.

Der volle Inhalt der Quelle

Annotation:

Purpose/Background: Postoperative nausea and vomiting (PONV) is a frequent complaint in the postoperative period, which can delay discharge, result in readmission, and increase cost for patients and facilities. Inducing paralysis is common in anesthesia, as is utilizing the drugs neostigmine and sugammadex as reversal agents for non-depolarizing neuromuscular blockers. Many studies are available that compare these two drugs to determine if neostigmine increases the risk of PONV over sugammadex. Sugammadex has a more favorable pharmacologic profile and may improve patient outcomes by reducing PONV. Methods: This review included screening a total of 39 studies and peer-reviewed articles that looked at patients undergoing general anesthesia who received non-depolarizing neuromuscular blockers requiring either neostigmine or sugammadex for reversal, along with their respective PONV rates. 8 articles were included, while 31 articles were removed based on our exclusion criteria. These were published between 2014 and 2020 exclusively. The key words used were “neostigmine”, “sugammadex”, “PONV”, along with combinations “paralytic reversal agents and PONV”. This search was performed on the scholarly database MEDLINE. The data items were PONV rates in neostigmine group, PONV rates in sugammadex group, incidence of postoperative analgesic consumption in neostigmine group, and incidence of postoperative analgesic consumption in sugammadex group. Results: Despite numerical differences being noted in the incidence of PONV with sugammadex over reversal with neostigmine, there did not appear to be any statistically significant data in the multiple peer-reviewed trials included in our review, for not one of the 8 studies concluded that there was a higher incidence of PONV in one drug or the other of an y clinical relevance. Although the side-effect profile tended to be better in the sugammadex group than neostigmine in areas other than PONV, there was not sufficient evidence to conclude that one drug was superior to the other in causing a direct reduction of PONV. Implications for Nursing Practice: There were variable but slight differences noted between both drug groups in PONV rates, but it remained that none of the studies determined it was statically significant or clinically conclusive. This review did, however, note other advantages to sugammadex over neostigmine, including its pharmacologic profile of more efficiently reversing non-depolarizing neuromuscular blocking drugs and its more favorable pharmacokinetics. This lack of statistically significant evidence found within these studies consequentially does not support pharmacologic decision-making of one drug in favor of the other for reducing PONV; therefore, PONV alone is not a sufficient rationale for a provider to justify using one reversal over another at the current time until further research proves otherwise.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Acred, Aleksander, Milena Devineni und Lindsey Blake. Opioid Free Anesthesia to Prevent Post Operative Nausea/Vomiting. University of Tennessee Health Science Center, Juli 2021. http://dx.doi.org/10.21007/con.dnp.2021.0006.

Der volle Inhalt der Quelle

Annotation:

Purpose The purpose of this study is to compare the incidence of post-operative nausea and vomiting (PONV) in opioid-utilizing and opioid-free general anesthesia. Background PONV is an extremely common, potentially dangerous side effect of general anesthesia. PONV is caused by a collection of anesthetic and surgical interventions. Current practice to prevent PONV is to use 1-2 antiemetics during surgery, identify high risk patients and utilize tracheal intubation over laryngeal airways when indicated. Current research suggests minimizing the use of volatile anesthetics and opioids can reduce the incidence of PONV, but this does not reflect current practice. Methods In this scoping review, the MeSH search terms used to collect data were “anesthesia”, “postoperative nausea and vomiting”, “morbidity”, “retrospective studies”, “anesthesia, general”, “analgesics, opioid”, “pain postoperative”, “pain management” and “anesthesia, intravenous”. The Discovery Search engine, AccessMedicine and UpToDate were the search engines used to research this data. Filters were applied to these searches to ensure all the literature was peer-reviewed, full-text and preferably from academic journals. Results Opioid free anesthesia was found to decrease PONV by 69%. PONV incidence was overwhelming decreased with opioid free anesthesia in every study that was reviewed. Implications The future direction of opioid-free anesthesia and PONV prevention are broad topics to discuss, due to the nature of anesthesia. Administration of TIVA, esmolol and ketamine, as well as the decision to withhold opioids, are solely up to the anesthesia provider’s discretion. Increasing research and education in the importance of opioid-free anesthesia to decrease the incidence of PONV will be necessary to ensure anesthesia providers choose this protocol in their practice.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Scholl, Madison, Miranda Morrison, Abbey Ramsey, Alexandria Sawicki und Dwayne Accardo. Impact of Opioid-Free Anesthesia on Postoperative Nausea & Vomiting: A Scoping Review. University of Tennessee Health Science Center, April 2023. http://dx.doi.org/10.21007/con.dnp.2023.0068.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lao, Lixing. A Controlled Study Using Acupuncture as an Adjuvant to Treat Chemotherapy-Induced Nausea and Vomiting. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada403341.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lao, Lixing, und Brian Berman. A Controlled Study Using Acupuncture as an Adjuvant to Treat Chemotherapy-Induced Nausea and Vomiting. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada411305.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lao, Lixing. A Controlled Study Using Acupuncture as an Adjuvant to Treat Chemotherpay-Induced Nausea and Vomiting. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada392239.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Stewart, Jada, Reagan Revon, Samantha Castellaw, Ashlee Roberts, Dwayne Accardo, Bobby Bellflower und Laura Reed. Efficacy of Aprepitant and Ondansetron in Managing Postoperative Nausea and Vomiting in Perioperative Obese Patients. University of Tennessee Health Science Center, Mai 2025. https://doi.org/10.21007/con.dnp.2025.0120.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!